Literature DB >> 659624

Synthesis of DNA and poly(adenosine diphosphate ribose) in normal and chronic lymphocytic leukemia lymphocytes.

N A Berger, J W Adams, G W Sikorski, S J Petzold, W T Shearer.   

Abstract

Peripheral blood lymphocytes were isolated from 9 patients with chronic lymphocytic leukemia (CLL) and 12 normal control donors. The cells were assayed for synthesis of DNA and poly-(adenosine diphosphate ribose) (poly[ADPR]) immediately after isolation and on successive days following their treatment with phytohemagglutinin (PHA). Two different techniques were used to measure DNA synthesis. In the standard technique, DNA synthesis was measured by incubating intact cells with [(3)H]deoxythymidine. In the new technique, the lymphocytes were first rendered permeable to nucleotides, then DNA synthesis was measured by incubating them with [(3)H]deoxythymidine triphosphate in the presence of deoxyATP, deoxyGTP, deoxyCTP, ATP, and Mg(++). Both assays showed the anticipated rise in DNA synthesis after PHA stimulation of normal cells. PHA-stimulated lymphocytes from patients with CLL demonstrated low levels of DNA synthesis in both assay systems. The initial levels of poly(ADPR) synthesis were greater in CLL lymphocytes than in normal cells. Studies with a T-cell-depleted population of normal cells showed the same activity for poly(ADPR) synthesis that was demonstrated by the original population of normal cells. PHA stimulation produced an increase in poly(ADPR) synthesis in both the normal and CLL cells. The increase in poly(ADPR) synthesis in normal cells was coincident with the increase in DNA synthesis. The increase in poly(ADPR) synthesis in the CLL cells was dissociated from the delayed and diminished increase in DNA synthesis. Thus, CLL cells have higher than normal initial levels of poly(ADPR) synthesis. Poly(ADPR) synthesis is dissociated from DNA synthesis in CLL cells whereas it varies directly with DNA synthesis in normal lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659624      PMCID: PMC371743          DOI: 10.1172/JCI109094

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  DNA synthesis in human lymphocyts: intermediates in DNA synthesis, in vitro and in vivo.

Authors:  B Y Tseng; M Goulian
Journal:  J Mol Biol       Date:  1975-12-05       Impact factor: 5.469

Review 2.  Recent excitement in the DNA replication problem.

Authors:  B Alberts; R Sternglanz
Journal:  Nature       Date:  1977-10-20       Impact factor: 49.962

3.  Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells.

Authors:  F Quagliata; D Faig; M Conklyn; R Silber
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

4.  Effect of phytohemagglutinin on enzymes of thymidine salvage pathway of cultured chronic lymphatic leukemic lymphocytes.

Authors:  Y Rabinowitz; P Wong; B A Wilhite
Journal:  Blood       Date:  1970-02       Impact factor: 22.113

5.  Studies on the polymer of adenosine diphosphate ribose. I. Enzymic formation from nicotinamide adenine dinuclotide in mammalian nuclei.

Authors:  Y Nishizuka; K Ueda; K Nakazawa; O Hayaishi
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

6.  Cell cycle phase specificity of antitumor agents.

Authors:  B K Bhuyan; L G Scheidt; T J Fraser
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

7.  The delayed response of c0ronic lymphocytic leukemia lymphocytes to phytohemagglutinin in vitro.

Authors:  K Havemann; A D Rubin
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

8.  Poly (adnenosine diphosphoribose) synthase activity of isolated nuclei of normal and leukemic leukocytes.

Authors:  L Burzio; L Reich; S S Koide
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

9.  Description of a permeable eukaryotic cell system to study agents affecting DNA synthesis: demonstration that cytembena is a direct inhibitor of replicative DNA synthesis.

Authors:  N A Berger; G Weber
Journal:  J Natl Cancer Inst       Date:  1977-04       Impact factor: 13.506

10.  Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations.

Authors:  R Silber; M Conklyn; G Grusky; D Zucker-Franklin
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more
  15 in total

1.  Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies.

Authors:  Shailly Mehrotra; Mathangi Gopalakrishnan; Jogarao Gobburu; Jacqueline M Greer; Richard Piekarz; Judith E Karp; Keith Pratz; Michelle A Rudek
Journal:  Br J Clin Pharmacol       Date:  2017-03-19       Impact factor: 4.335

2.  ADP-ribosyltransferase in isolated nuclei from sea-urchin embryos.

Authors:  A Isoai; I Yasumasu
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

Review 3.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

Review 4.  Regulation of mRNA polyadenylation-deadenylation.

Authors:  C M Tsiapalis
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

5.  Nucleotide-stimulated proteolysis of histone H1.

Authors:  C S Surowy; N A Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Role of nicotinamide adenine dinucleotide and adenosine triphosphate in glucocorticoid-induced cytotoxicity in susceptible lymphoid cells.

Authors:  N A Berger; S J Berger; D C Sudar; C W Distelhorst
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Association of poly(adenosine diphosphoribose) synthesis with DNA damage and repair in normal human lymphocytes.

Authors:  N A Berger; G W Sikorski; S J Petzold; K K Kurohara
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

8.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

Authors:  I U Schraufstatter; D B Hinshaw; P A Hyslop; R G Spragg; C G Cochrane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Some early events in the primary mitogenic stimulation of lymphocytes differ from later interleukin stimulation and other quiescence to growth activation systems.

Authors:  A P Johnstone; D Darling
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

10.  Poly(ADP-ribose) synthesis, a marker of granulocyte differentiation.

Authors:  K Ikai; K Ueda; M Fukushima; T Nakamura; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.